MINUCCI, SAVERIO
 Distribuzione geografica
Continente #
EU - Europa 9.000
AS - Asia 5.731
NA - Nord America 5.510
SA - Sud America 307
OC - Oceania 211
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.821
Nazione #
US - Stati Uniti d'America 5.301
CN - Cina 3.596
DE - Germania 3.310
GB - Regno Unito 2.259
IT - Italia 1.051
SE - Svezia 616
SG - Singapore 496
RU - Federazione Russa 334
KR - Corea 326
JP - Giappone 247
IE - Irlanda 235
IN - India 228
BR - Brasile 227
TR - Turchia 218
FR - Francia 214
UA - Ucraina 200
AU - Australia 198
TW - Taiwan 179
CA - Canada 174
NL - Olanda 123
FI - Finlandia 117
HK - Hong Kong 112
ES - Italia 88
EU - Europa 86
BE - Belgio 68
PL - Polonia 66
ID - Indonesia 60
CH - Svizzera 59
DK - Danimarca 55
TH - Thailandia 55
MY - Malesia 51
CO - Colombia 41
AT - Austria 35
GR - Grecia 35
NO - Norvegia 33
VN - Vietnam 32
MX - Messico 29
IR - Iran 26
PT - Portogallo 21
PH - Filippine 20
CL - Cile 16
PK - Pakistan 14
RO - Romania 14
CZ - Repubblica Ceca 13
NZ - Nuova Zelanda 13
ZA - Sudafrica 13
CY - Cipro 12
SK - Slovacchia (Repubblica Slovacca) 11
ET - Etiopia 10
HU - Ungheria 10
MO - Macao, regione amministrativa speciale della Cina 10
AE - Emirati Arabi Uniti 9
SI - Slovenia 9
EC - Ecuador 8
EG - Egitto 8
IQ - Iraq 6
MT - Malta 6
NG - Nigeria 6
JO - Giordania 5
LB - Libano 5
PE - Perù 5
IL - Israele 4
AR - Argentina 3
BN - Brunei Darussalam 3
HR - Croazia 3
LT - Lituania 3
LU - Lussemburgo 3
MA - Marocco 3
UY - Uruguay 3
VE - Venezuela 3
VI - Stati Uniti Isole Vergini 3
GH - Ghana 2
IS - Islanda 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
MG - Madagascar 2
ML - Mali 2
MM - Myanmar 2
MU - Mauritius 2
QA - Qatar 2
RS - Serbia 2
SA - Arabia Saudita 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
BT - Bhutan 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GF - Guiana Francese 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
NP - Nepal 1
PR - Porto Rico 1
Totale 20.897
Città #
Frankfurt am Main 2.593
Southend 1.897
Beijing 589
Hangzhou 555
Chandler 363
Seattle 363
Milan 360
Singapore 345
Shanghai 304
Ashburn 281
Wilmington 241
Fairfield 238
Dublin 225
Nanjing 224
Princeton 220
Guangzhou 203
Dearborn 174
Houston 171
Redwood City 171
Ann Arbor 163
Jacksonville 150
Woodbridge 132
Taipei 116
Wuhan 111
Shenyang 97
Cambridge 94
Des Moines 88
Mountain View 87
Redmond 87
Changsha 81
Bengaluru 78
Jinan 77
Chengdu 73
Seoul 70
Sakarya 66
Boardman 61
Tianjin 61
Hanover 59
Boise 58
New York 58
Santa Clara 57
Zhengzhou 56
Tokyo 55
Phoenix 51
Hong Kong 50
Toronto 49
Warsaw 46
Serra 44
Andover 41
Los Angeles 41
Nanchang 41
Jakarta 39
Bogotá 38
Ottawa 37
Pittsburgh 36
Xian 35
Fuzhou 34
Somerville 34
Berlin 31
Hefei 31
Brussels 30
Changchun 30
Dallas 30
Chongqing 29
Hebei 29
London 29
Rome 29
Evanston 27
Rochester 27
Bangkok 26
Kunming 26
São Paulo 26
Brisbane 25
Istanbul 25
Munich 25
Boston 23
San Diego 23
Shenzhen 23
Athens 21
Atlanta 20
Chicago 20
Kuala Lumpur 20
Sunnyvale 20
Harbin 19
Jiaxing 18
Suzhou 18
Hanoi 17
Helsinki 17
Philadelphia 17
Pune 17
Sydney 17
Bethesda 16
Birmingham 16
Central 16
Düsseldorf 16
Eitensheim 16
Central District 15
Columbus 15
Durham 15
Ningbo 15
Totale 13.093
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 3.911
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer 1.282
Blood orange juice inhibits fat accumulation in mice 1.073
Entinostat for the treatment of breast cancer 687
Guidelines for the use and interpretation of assays for monitoring autophagy 436
Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors 419
A dual role for Hdac1 : oncosuppressor in tumorigenesis, oncogene in tumor maintenance 405
Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner 405
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 313
Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis 255
MicroRNA-222 Regulates Melanoma Plasticity 231
Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples 224
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis 223
Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo 220
Differentiation response of acute promyelocytic leukemia cells and PML/RAR alpha leukemogenic activity studies by real-time RT-PCR 211
Mechanisms of selective anticancer action of histone deacetylase inhibitors 198
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer 186
The DNA demethylating agent decitabine activates the TRAIL pathway and induces apoptosis in acute myeloid leukemia 184
Immunohistochemical detection of Ym1/Ym2 chitinase-like lectins associated with hyalinosis and polypoid adenomas of the transitional epithelium in a mouse with acute myeloid leukemia 182
Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity 182
Il succo di arancia rossa inibisce l’accumulo di grassi in modelli animali 177
DNA Methyl-Transferase inhibitors and Histone De-Acetylases inhibitors contrast leukemias reactivating the same apoptosis pathways 171
Epigenomic profiling of cancer cells 165
Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples 164
Redundant function of retinoic acid receptor isoforms in leukemogenesis unravels a prominent function of genome topology and architecture in the selection of mutagenic events in cancer 162
New method to detect histone acetylation levels by flow cytometry 160
Assessment of histone acetylation levels in relation to cell cycle phase 160
Acetylation: a novel link between double-strand break repair and autophagy 153
Chromatin accessibility, p300 and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia 153
Cluster assembled nanostructured TiO2 film mediates efficient and safe retroviral gene transduction in primary adult human melanocytes for ex-vivo gene therapy 151
The methyl-CpG binding protein MBD1 is required for PML-RARα function 151
HDACs link the DNA damage response, processing of double-strand breaks and autophagy 151
Tranylcypromine Derivatives Useful as Inhibitors Demethylases LSD1 and LSD2 149
Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer 147
Histone deacetylases and epigenetic therapies of hematological malignancies 145
PAT-ChIP coupled with laser microdissection allows the study of chromatin in selected cell populations from paraffin-embedded patient samples 145
PP2A Controls Genome Integrity by Integrating Nutrient-Sensing and Metabolic Pathways with the DNA Damage Response 143
Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technology 142
Redox-mediated suberoylanilide hydroxamic acid sensitivity in breast cancer 138
Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML 136
Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment 133
Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice 133
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 133
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation 131
BLUEPRINT to decode the epigenetic signature written in blood 130
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one- carbon metabolism in breast cancer 128
Molecular and biological analysis of histone deacetylase inhibitors with diverse specificities 126
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach 126
The International Human Epigenome Consortium : A Blueprint for Scientific Collaboration and Discovery 126
Common themes in the pathogenesis of acute myeloid leukemia 124
Retinoid X receptor-selective ligands produce malformations in Xenopus embryos 123
Self-renewal of tumor cells : Epigenetic determinants of the cancer stem cell phenotype 123
Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells 121
Immunocell-array for molecular dissection of multiple signaling pathways in mammalian cells 120
Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors 120
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation 120
Determinants of oncogenic transformation in acute promyelocytic leukemia : the hetero-union makes the force 119
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells 119
Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies 117
Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesis 116
PML is required for telomere stability in non-neoplastic human cells 111
Blueprint to decode the epigenetic signature written in blood 110
Extensive and systematic rewiring of histone post-translational modifications in cancer model systems 110
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia 109
The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells 109
Impairment of p53 acetylation, stability and function by an oncogenic transcription factor 106
Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc 106
Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis 106
Leukemia-associated fusion proteins : multiple mechanisms of action to drive cell transformation 105
Dual modulation of MCL-1 and mTOR determines the response to sunitinib 103
p66Shc-generated oxidative signal promotes fat accumulation 102
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype 102
Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissue 100
Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy 100
MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function 99
Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO 97
A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis 97
Eosinophilic crystals as a distinctive morphologic feature of a hyaline droplet nephropathy in a mouse model of acute myelogenous leukaemia 96
Erratum: PML is required for telomere stability in non-neoplastic human cells (vol 35, pg 1811, 2016) 96
Anticancer innovative therapy congress: Highlights from the 10th anniversary edition 95
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway 94
A Refined Single Cell Landscape of Haematopoiesis in the Mouse Foetal Liver 94
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response 93
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside 92
A redundant oncogenic potential of the retinoic receptor (RAR) alpha, beta and gamma isoforms in acute promyelocytic leukemia 88
Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein 88
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 88
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras 85
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma 83
The APL-associated fusion proteins 82
Sex and cancer immunotherapy: Current understanding and challenges 80
Co-targeting leukemia-initiating cells and leukemia bulk leads to disease eradication 80
Semantic and geographical analysis of COVID-19 trials reveals a fragmented clinical research landscape likely to impair informativeness 79
Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation 79
PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors 79
Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810 79
Long non-coding RNA TINCR suppresses metastatic melanoma dissemination by preventing ATF4 translation 79
The tripartite motif family identifies cell compartments 77
Targeting protein inactivation through an oligomerization chain reaction 76
Retinoid receptors in health and disease: co-regulators and the chromatin connection 76
Totale 20.508
Categoria #
all - tutte 44.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.966 0 0 0 0 231 307 281 184 336 285 193 149
2020/20212.513 153 239 190 100 201 217 195 136 315 215 357 195
2021/20222.012 154 127 122 168 164 177 168 153 209 143 170 257
2022/20231.915 240 166 149 224 182 328 96 104 170 68 85 103
2023/20243.446 93 115 87 136 327 242 421 381 227 428 488 501
2024/20251.886 437 517 357 405 170 0 0 0 0 0 0 0
Totale 21.677